Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Biotech · Dual Momentum | DOWN 100% | Dual Momentum — blends long + intermediate trend. INSM ranks #3 of 8 in Biotech (100% bearish percentile, signal -26.7%), so the agent calls it DOWN for the next session. |
| Biotech · Mean-Reversion | UP 100% | Mean-Reversion — contrarian on the trailing return. INSM ranks #1 of 8 in Biotech (100% bullish percentile, recent move -3.4%, fading it), so the agent calls it UP for the next session. |
| Biotech · Bollinger Reversion | UP 86% | Bollinger Reversion — fade moves outside the bands. INSM ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · 52-Week-High | DOWN 86% | 52-Week-High — proximity to the trailing high. INSM ranks #4 of 8 in Biotech (86% bearish percentile, 59% of its 52-week high), so the agent calls it DOWN for the next session. |
| Biotech · LightGBM | DOWN 86% | LightGBM — a gradient-boosted model fit on this basket's recent features. INSM ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Low Volatility | DOWN 86% | Low Volatility — the low-volatility anomaly. INSM ranks #4 of 8 in Biotech (86% bearish percentile, annualized volatility 80%), so the agent calls it DOWN for the next session. |
| Biotech · MACD | UP 86% | MACD — MACD histogram momentum crossover. INSM ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Meta-Ensemble | DOWN 86% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. INSM ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · OBV Trend | DOWN 86% | OBV Trend — on-balance-volume accumulation. INSM ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Volume Thrust | UP 86% | Volume Thrust — volume-confirmed accumulation. INSM ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 57% | Momentum — trailing return (trend-following). INSM ranks #4 of 8 in Biotech (57% bullish percentile, signal +18.4%), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 29% | Donchian — position within the Donchian channel. INSM ranks #6 of 8 in Biotech (29% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum Acceleration | UP | Momentum Acceleration — trend speeding up. INSM ranks #8 of 8 in Biotech (0% bullish percentile, signal -36.7%), so the agent calls it UP for the next session. |
Best agents on INSM (graded record)
| Mean-Reversion Agent | 83% | 5/6 correct | DOWN |
| Biotech · Mean-Reversion | 59% | 16/27 correct | UP |
| Biotech · Bollinger Reversion | 59% | 13/22 correct | UP |
| Biotech · Regime Switch | 58% | 15/26 correct | UP |
| Biotech · Low Volatility | 57% | 23/40 correct | DOWN |
| Biotech · Meta-Ensemble | 57% | 21/37 correct | DOWN |
| Biotech · Trend Strength | 57% | 17/30 correct | DOWN |
| Biotech · Dual Momentum | 56% | 23/41 correct | DOWN |
| Biotech · 52-Week-High | 56% | 23/41 correct | DOWN |
| Biotech · LightGBM | 55% | 12/22 correct | DOWN |
Recent news
| 2026-08-24 | Mizuho raises Insmed stock price target to $195 on Japan approval - Investing.com · Investing.com |
| 2026-08-24 | Mizuho raises Insmed stock price target to $195 on Japan approval - Investing.com Canada · Investing.com Canada |
| 2026-08-24 | Mizuho raises Insmed stock price target to $195 on Japan approval · investing_com |
| 2026-08-24 | Mizuho raises Insmed stock price target to $195 on Japan approval - Investing.com · Investing.com |
| 2026-08-24 | BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease · yf_tkr_INSM |
| 2026-08-20 | Insmed Slides 4.3% as Recent Insider Sales and Post-Earnings Profit-Taking Weigh on Shares - Quiver Quantitative · Quiver Quantitative |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。